Sublingual misoprostol and hyperpyrexia: case report with temperature curve

BMC Res Notes. 2017 Jul 26;10(1):329. doi: 10.1186/s13104-017-2661-2.

Abstract

Background: Misoprostol has a wide range of applications in obstetrics and gynaecology. It is widely recommended by WHO, FIGO and ACOG for the treatment of postpartum haemorrhage due to it safety and cost-effectiveness. However, usage might be associated to hyperpyrexia and shivering.

Case presentation: We present a 30 year old Cameroonian female gravida 1 para 1 who had a vaginal delivery at 40 weeks of gestation complicated by primary postpartum haemorrhage (PPH). PPH was managed by sublingual misoprostol that induced shivering and hyperpyrexia managed successfully with paracetamol and cooling.

Conclusions: The occurrence of fever and shivering should be kept in mind when administering misoprostol for PPH.

Keywords: Case report; Hyperpyrexia; Misoprostol; Temperature.

Publication types

  • Case Reports

MeSH terms

  • Administration, Sublingual
  • Adult
  • Female
  • Fever / chemically induced*
  • Humans
  • Misoprostol / administration & dosage
  • Misoprostol / adverse effects*
  • Oxytocics / administration & dosage
  • Oxytocics / adverse effects*
  • Postpartum Hemorrhage / drug therapy*
  • Pregnancy

Substances

  • Oxytocics
  • Misoprostol